Solace Therapeutics

Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies.

The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time.

Solace Therapeutics headquartered in United States, North America, operates in the Health Care, Medical Device, Therapeutics sector. The company focuses on Health Care and has secured $2.2B in funding across 60 round(s). With a team of 11-50 employees, Solace Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - Solace Therapeutics, raised $7.0M. Discover more about their projects, partnerships, and impact on our platform.